CCND1 and colorectal cancer: The positive influences of CCND1 870A allele are thus consistent with one another, even though they do not concord with the sole published study having analyzed the impact of CCND1 A870G polymorphism on the outcome of advanced colorectal cancer patients receiving cetuximab therapy [36].